Yep three years, perhaps we need one final capitulation like we had back in March 2020 before we begin our ascent.
If we can expect early readouts as soon as Nov, that really is not far away.
The ann. that kicked off the rerate back in 2020 was "Ann: Successful Efficacy Result on Path to First in Human Studies" for RP. It's incredible that we'll be commencing first patient dosing this month and yet are trading at the same price as back then (albeit we have incurred some dilution since then).
Lets hope a big blue volume bar on the weekly timeframe isn't far away
PYC Price at posting:
6.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)